Copenhagen, Denmark, September 4, 2007: Rheoscience A/S, a Danish biotechnology company discovering and developing new drugs for diabetes and obesity, today announces the appointment of Swami Subramaniam, MD, PhD to the newly created position of Director, Business Development. Dr. Subramaniam will also continue in his position as Head, India Operations for Rheoscience, which he assumed in January 2006.
